Medical Devices industry M&A deals total $21.21bn in US in January 2021

Total medical devices industry M&A deals worth $21.21bn were announced in the US in January 2021, with OptumInsight’s $13bn acquisition of Change Healthcare being the sector’s biggest investment, according to GlobalData’s deals database.

The value marked an increase of 238.8% over the previous month of $6.26bn and a rise of 307.1% when compared with the last 12-month average of $5.21bn.

The US held a 91.19% share of the global medical devices industry M&A deal value that totalled $23.26bn in January 2021.

In terms of M&A deal activity, the US recorded 25 deals during January 2021, marking a decrease of 19.35% over the previous month and a rise of 25.00% over the 12-month average.

US medical devices industry M&A deals in January 2021: Top deals

The top five medical devices industry M&A deals accounted for 94.3% of the overall value during January 2021.

The combined value of the top five medical devices M&A deals stood at $20.01bn, against the overall value of $21.21bn recorded for the month.

The top five medical devices industry M&A deals of January 2021 tracked by GlobalData were:

1) OptumInsight’s $13bn acquisition of Change Healthcare

2) The $4.6bn acquisition of Cantel Medical by Steris

3) Boston Scientific’ $1.23bn acquisition of Preventice.

4) The $635m acquisition of Capsule Technologies by Koninklijke Philips

5) Thermo Fisher Scientific’s acquisition of Mesa Biotech for $550m.